A narrative review on diagnosis and treatment of ifosfamide-induced encephalopathy, the perspective of a EURACAN reference center for sarcomas.

Front Pharmacol · 2025 · PMC11885513 · PMID 40061960

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

(2022) , that included one randomized clinical trial (RCT) and eight retrospective cohort studies reporting a positive trend not reaching statistical significance between IIE and the concomitant use of IFO and aprepitant or fosaprepitant.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.